Recent News

White House Accepts NASPGHAN’s Bold Commitment to End Hunger and Build Healthy Communities

* BREAKING NEWS * White House Accepts NASPGHAN’s Bold Commitment to End Hunger and Build Healthy Communities February 27, 2024 – Today the Biden-Harris Administration announced new commitments to the White House Challenge to End Hunger and Build Healthy Communities. NASPGHAN is excited to announce the White House has accepted its commitment of $25,000 to

read more

Call for Webinar proposals!

Do you, your SIG or your committee have a concept for a NASPGHAN webinar? We are pleased to announce a new streamlined method for the submission and review of webinar proposals. Proposals will be reviewed by the Professional Education Committee twice a year (February 15 and July 15 for 2024) and then scheduled accordingly if

read more

NASPGHAN ALERT: Guidance for Flovent HFA Upcoming Discontinuation Used For The Treatment of Eosinophilic Esophagitis

Please see the following alert from the EGID Special Interest Group. Situation: Brand name Flovent HFA will no longer be manufactured after December 31, 2023. Background: • Flovent HFA is a commonly utilized swallowed topical steroid treatment for patients with eosinophilic esophagitis (EoE). It works by the patient swallowing the aerosolized medication dispensed by a

read more

New Video on Treatment of EoE

Watch our new video on the Treatment of EoE This video presents information about the current treatment options for Eosinophilic esophagitis (EoE). It does NOT address other types of food allergies or eosinophilic conditions beyond the esophagus. Always consult with your health care providers when making decisions about treatment. Supported by an educational grant from

read more

Partners:

The Association of Pediatric Gastroenterology and Nutrition Nurses
Help & Hope for Children with Digestive Disorders
Journal of Pediatric Gastroenterology and Nutrition
JPGN Reports